ADPT - Adaptive Biotechnologies Corp
14.04
-0.170 -1.211%
Share volume: 1,229,374
Last Updated: 04-28-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.20%
PREVIOUS CLOSE
CHG
CHG%
$14.21
-0.17
-0.01%
Summary score
37%
Profitability
35%
Dept financing
33%
Liquidity
70%
Performance
31%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 31-Dec-2021 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-5.89%
Return on sales
-91.39%
Return on invested capital
0%
Total debt ratio
52.4%
Debt ratio change over timeo
-3.35%
Current Ratio
4.09%
Quick Ratio
3.94%
Cash Position Ratio
0.84%
Short-term ratios 31-Dec-2024 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-2.81%
Return on sales
-26.46%
Return on invested capital
0%
Total debt ratio
60.55%
Debt ratio change over timeo
0%
Current Ratio
3.12%
Quick Ratio
3.01%
Cash Position Ratio
0.62%
Last quarter ratios 31-Dec-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-2.49%
Return on sales
-17.82%
Return on invested capital
0%
Total debt ratio
57.33%
Debt ratio change over time
0%
Current Ratio
3.34%
Quick Ratio
3.23%
Cash Position Ratio
0.78%
Performance ratios (change over 4 years) 31-Dec-2021 - 31-Dec-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
-51.34%
Return on sales
981.33%
Return on invested capital
0%
Total debt ratio
-335.32%
Debt ratio change over time
-3.35%
Current Ratio
-25.12%
Quick Ratio
-23.91%
Cash Position Ratio
-7.61%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ADPT | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 5.97% | 8.91% |
| Return on assets | -5.89% | 2.97% | 3.34% | 2.04% |
| Return on sales | -91.39% | 27.71% | 27.82% | 21.49% |
| Return on invested capital | 0% | 0% | 3.51% | 10.25% |
| Profitability | 0% | 47% | 75% | 85% |
| Total debt ratio | 52.4% | 93.27% | 65.75% | 43.64% |
| Debt ratio change over time | -3.35% | 14.34% | 187.33% | 9.75% |
| Dept financing | 14% | 27% | 43% | 13% |
| Current Ratio | 3.12% | 1.22% | 1.42% | 2.33% |
| Quick Ratio | 3.01% | 0.94% | 1.27% | 1.72% |
| Cash Position Ratio | 0.62% | 0.39% | 0.58% | 0.86% |
| Liquididy | 75% | 42% | 32% | 45% |
| Short-term ratios | ADPT | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -2.81% | 3.27% | 4.7% | 1.36% |
| Return on sales | -26.46% | 24.35% | 34.09% | 15.11% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 35% | 50% | 18% |
| Total debt ratio | 60.55% | 91.09% | 63.87% | 38.21% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 42% | 25% | 18% | 10% |
| Current Ratio | 3.12% | 1.22% | 1.42% | 2.33% |
| Quick Ratio | 3.01% | 0.94% | 1.27% | 1.72% |
| Cash Position Ratio | 0.62% | 0.39% | 0.58% | 0.86% |
| Liquididy | 68% | 29% | 39% | 58% |